当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2014年
10期
121-122
,共2页
降钙素原%全身炎症反应综合征%普外科
降鈣素原%全身炎癥反應綜閤徵%普外科
강개소원%전신염증반응종합정%보외과
Procalcitonin%Systemic inflammatory response syndrome%General surgery department
目的:探讨降钙素原在普外科创伤患者术后全身炎症反应综合征中的应用。方法选择广东省东莞市东莞寮步医院普外科收治的100例创伤术后发生全身炎症反应综合征的患者,随机均分为2组。降钙素原组使用抗生素依据血清降钙素原浓度,对照组使用抗生素依据抗生素使用指南。记录两组治疗有效例数和死亡例数,记录2组使用抗生素例数,记录2组住院时间和住院费用。结果2组患者的有效率和死亡率比较,差异无统计学意义;降钙素原组使用抗生素的患者比对照组少,差异有统计学意义(P<0.05);2组患者住院时间比较,差异无统计学意义;降钙素原组患者的住院费用少于对照组,差异有统计学意义(P<0.05)。结论应用降钙素原指导抗生素使用,可使患者抗生素使用率降低和医疗费用减少。
目的:探討降鈣素原在普外科創傷患者術後全身炎癥反應綜閤徵中的應用。方法選擇廣東省東莞市東莞寮步醫院普外科收治的100例創傷術後髮生全身炎癥反應綜閤徵的患者,隨機均分為2組。降鈣素原組使用抗生素依據血清降鈣素原濃度,對照組使用抗生素依據抗生素使用指南。記錄兩組治療有效例數和死亡例數,記錄2組使用抗生素例數,記錄2組住院時間和住院費用。結果2組患者的有效率和死亡率比較,差異無統計學意義;降鈣素原組使用抗生素的患者比對照組少,差異有統計學意義(P<0.05);2組患者住院時間比較,差異無統計學意義;降鈣素原組患者的住院費用少于對照組,差異有統計學意義(P<0.05)。結論應用降鈣素原指導抗生素使用,可使患者抗生素使用率降低和醫療費用減少。
목적:탐토강개소원재보외과창상환자술후전신염증반응종합정중적응용。방법선택광동성동완시동완료보의원보외과수치적100례창상술후발생전신염증반응종합정적환자,수궤균분위2조。강개소원조사용항생소의거혈청강개소원농도,대조조사용항생소의거항생소사용지남。기록량조치료유효례수화사망례수,기록2조사용항생소례수,기록2조주원시간화주원비용。결과2조환자적유효솔화사망솔비교,차이무통계학의의;강개소원조사용항생소적환자비대조조소,차이유통계학의의(P<0.05);2조환자주원시간비교,차이무통계학의의;강개소원조환자적주원비용소우대조조,차이유통계학의의(P<0.05)。결론응용강개소원지도항생소사용,가사환자항생소사용솔강저화의료비용감소。
Objective To investigate the application of procalcitonin in the trauma patients underwent systemic inflammatory response syndrome after operation in general surgery department.Method One hundred trauma patients underwent systemic inflammatory response syndrome after operation in general surgery department were divided into two groups: procalcitonin group and control group. Antibiotics were used according to serum procalcitonin concentration in the procalcitonin group. Antibiotics were used according to antibiotic use guide in the control group. The effective rate, mortality, antibiotic use rate, hospital stays, hospitalization expenses in both groups were recorded.Results There were no significant difference in the effective rate and mortality between two groups.The antibiotic use rate in the procalcitonin group was lower than it in the control group(P<0.05). There were no significant difference in the hospital stays between two groups.The hospitalization expenses in the procalcitonin group were less than those in the control group(P<0.05).Conclusion Application of procalcitonin in antibiotics use can decrease the antibiotic use rate and the hospitalization expenses.